Targeting B7-H3 in prostate cancer: Preclinical proof of concept with MGC018, an investigational anti-B7-H3 antibody-drug conjugate

被引：0
|
作者：
Scribner, Juniper A. [1 ]
Chen, Francine Z. [1 ]
De Costa, Anushka [1 ]
Li, Ying [1 ]
Chiechi, Michael [1 ]
Son, Thomas [1 ]
Hooley, Jeff [1 ]
Li, Jonathan [1 ]
Koenig, Scott [2 ]
Bohac, Chet [2 ]
Bonvini, Ezio [2 ]
Moore, Paul A. [2 ]
Loo, Deryk [1 ]
机构：
[1] MacroGenics Inc, Brisbane, CA USA
[2] MacroGenics Inc, Rockville, MD USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
330
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Investigating B7-H3 as a checkpoint and antibody drug conjugate target across prostate cancer variants- both androgen receptor dependent and independent
    Mundhara, Nikita
    Sharma, Shivang
    Tekoglu, Emirhan
    Baraban, Ezra G.
    Lack, Nathan A.
    Shenderov, Eugene
    CANCER RESEARCH, 2024, 84 (06)
  • [42] An Anti-B7-H4 Antibody Drug Conjugate for the Treatment of Breast Cancer
    Leong, Steven R.
    Liang, Wei-Ching
    Wu, Yan
    Crocker, Lisa
    Cheng, Eric
    Sampath, Deepak
    Ohri, Rachana
    Raab, Helga
    Hass, Philip E.
    Thinh Pham
    Firestein, Ron
    Li, Dongwei
    Schutten, Melissa
    Stagg, Nicola J.
    Ogasawara, Annie
    Koppada, Neelima
    Roth, Leslie
    Williams, Simon P.
    Lee, Byoung-Chul
    Chalouni, Cecile
    Peng, Ivan
    DeVoss, Jason
    Tremayne, Jarrod
    Polakis, Paul
    Polson, Andrew G.
    MOLECULAR PHARMACEUTICS, 2015, 12 (06) : 1717 - 1729
  • [43] Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer
    Han, Sai
    Wang, Ying
    Shi, Xuejiao
    Zong, Liju
    Liu, Lu
    Zhang, Juan
    Qian, Qiuhong
    Jin, Jing
    Ma, Yana
    Cui, Baoxia
    Yang, Xingsheng
    Kong, Beihua
    Zhang, Youzhong
    EXPERIMENTAL CELL RESEARCH, 2018, 371 (01) : 222 - 230
  • [44] A promising target for breast cancer: B7-H3
    Ying Jiang
    Jiayu Liu
    Lingyan Chen
    Zhiwen Qian
    Yan Zhang
    BMC Cancer, 24
  • [45] To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3
    Kanchan, Ranjana K.
    Doss, David
    Khan, Parvez
    Nasser, Mohd. Wasim
    Mahapatra, Sidharth
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2022, 1877 (05):
  • [46] In vivo efficacy of anti-B7-H3 antibody-drug conjugate (ADC) ifinatamab deruxtecan (I-DXd; DS-7300): An update from the Pediatric Preclinical In Vivo Testing (PIVOT) Program
    Gorlick, Richard
    Gill, Jonathan
    Zhang, Wendong
    Mosse, Yael
    Maris, John
    Groff, David
    Smith, Malcolm
    Teicher, Beverly
    Neuhauser, Steve
    Stearns, Tim
    Philip, Vivek
    Jocoy, Emily
    Chuang, Jeff
    Bult, Carol J.
    Hasegawa, Jun
    Qian, Xiaozhong
    Houghton, Peter
    Kurmasheva, Raushan
    CANCER RESEARCH, 2024, 84 (07)
  • [47] Clinical importance and therapeutic potential of targeting B7-H3 in pancreatic cancer
    Yamato, Ichiro
    Sho, Masayuki
    Nomi, Takeo
    Akahori, Takahiro
    Kanehiro, Hiromichi
    Shimada, Keiji
    Konishi, Noboru
    Yagita, Hideo
    Nakajima, Yoshiyuki
    CANCER RESEARCH, 2009, 69
  • [48] B7-H3 in Cancer - Beyond Immune Regulation
    Flem-Karlsen, Karine
    Fodstad, Oystein
    Tan, Ming
    Nunes-Xavier, Caroline E.
    TRENDS IN CANCER, 2018, 4 (06): : 401 - 404
  • [49] Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer
    Yamada, Yasutaka
    Venkadakrishnan, Varadha Balaji
    Mizuno, Kei
    Bakht, Martin
    Ku, Sheng-Yu
    Garcia, Maria Mica
    Beltran, Himisha
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (722)
  • [50] A Novel Anti-B7-H3 x Anti-CD3 Bispecific Antibody with Potent Antitumor Activity
    Feng, Yan
    Xie, Kun
    Yin, Yanxin
    Li, Bingyu
    Pi, Chenyu
    Xu, Xiaoqing
    Huang, Tao
    Zhang, Jingming
    Wang, Bo
    Gu, Hua
    Fang, Jianmin
    LIFE-BASEL, 2022, 12 (02):
12345